Today: 23 June 2026
HSBC share price: UK jobs data rattles sterling as HSBA heads for London open, results in sight
17 February 2026
1 min read

HSBC share price: UK jobs data rattles sterling as HSBA heads for London open, results in sight

London, February 17, 2026, 07:49 GMT — Premarket

  • HSBC (HSBA.L) hovered near 1,251.2 pence before trading started in London, following Monday’s gain of about 1%.
  • UK unemployment climbed, with wage growth easing—fueling the ongoing debate on when the Bank of England might move to cut rates.
  • UK inflation lands Wednesday, with traders keeping an eye out. HSBC’s annual numbers hit Feb. 25.

HSBC shares looked flat in early London trade Tuesday, with the stock indicated at 1,251.2 pence. Investors kept an eye on new UK labour numbers and recalibrated their interest-rate expectations.

Timing’s key here. HSBC—one of the heaviest names on the FTSE 100—has been tugging at the index, with bank stocks quick to react to every fresh data point out of the UK economy following the sharp volatility earlier this month.

At the heart of the trade: rate expectations. When rates drop, net interest income—the difference between what banks collect on loans and pay out on deposits—can get pinched, despite borrowers catching a break.

Britain’s unemployment rate ticked up in December, coming in at 5.2% versus 5.1% the month before. Wage growth, on one key measure, lost more steam than markets anticipated—slowing to 4.2% from 4.6%. Sterling slipped roughly 0.3%, last trading at $1.359.

HSBC ended Monday at 1,251.2 pence, rising 1.02% for the session. Shares moved in a range from 1,250.6p to 1,264.4p. Roughly 17.1 million shares traded hands, according to Investing.com.

Lenders caught a break Monday as sentiment picked up. The FTSE 100 gained 0.26% in London. Shares of major UK banks clawed back some ground after last week’s drop, triggered by concerns over new artificial intelligence models. According to Reuters, markets have already started factoring in a 25-basis-point rate cut (0.25 percentage point) next month. NatWest shares surged 4.7%, while Barclays booked a 1.5% rise.

“It looks like the AI scare trade has stalled heading into this week,” said Kathleen Brooks, research director at XTB. She highlighted some tentative rebound in the sectors that bore the brunt of the recent selling. Reuters

UK assets face a packed schedule in the days ahead. “We are going to keep an eye on the UK data this week,” said Mohamad Al-Saraf, FX and fixed income associate at Danske Bank. Traders are also watching the Bank of England’s policy outlook. Reuters

All eyes shift to company news next week. HSBC is set to post its 2025 annual results at 4 a.m. GMT on Wednesday, Feb. 25, with an investor and analyst meeting scheduled for later that morning, its investor site shows.

The report is set to shape conversations about earnings momentum and costs, as well as how quickly capital is coming back via dividends and buybacks. Investor focus will likely zero in on credit quality, and there’s fresh scrutiny on the performance of fee-based operations like wealth management.

The path’s anything but smooth. Quicker rate cuts chip away at bank margins, but if inflation comes in hotter, markets might have to delay easing bets—rattling the sector all over again.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Catheter Precision Surge: VTAK’s Patent Wins and Flyte Partnership Drive Stock Rally
    June 23, 2026, 8:28 AM EDT. Catheter Precision Inc. (VTAK) gained 34.5% in premarket trade, surging to $1.17 on June 23, 2026. The micro-cap medical-device company, valued at approximately $2.34 million, attracted attention due to new patent grants related to heart-failure and vascular closure technologies, and a strategic partnership between its aviation unit Flyte and sports agency GSE Worldwide. Catheter Precision also filed to register 68.1 million shares for resale, amplifying market volatility. CEO David Jenkins highlighted the patents as validation of years of work and potential assets for sale. Meanwhile, Flyte's aviation focus complements its cardiology business, with Volato Group-a private-aviation platform backed by Catheter Precision-recently securing a $2.2 million private equity round. The stock's small size and high volume have intensified price swings.

Latest articles

Catheter Precision Stock Suddenly Takes Off: Why VTAK Is on Traders’ Radar Today

Catheter Precision Stock Suddenly Takes Off: Why VTAK Is on Traders’ Radar Today

23 June 2026
Catheter Precision soared 34.5% premarket after registering 68.1 million shares for resale—25 times shares outstanding—amid new heart-failure patents, a Flyte sports partnership, and warnings of “substantial doubt” about its ability to continue as a going concern due to a $441,000 cash balance and $18.5 million deficit.
Ridgetech (RDGT) Stock Jumps in Premarket as Volume Surges

Ridgetech (RDGT) Stock Jumps in Premarket as Volume Surges

23 June 2026
Ridgetech shares soared 68.6% to $2.31 in Nasdaq premarket trading on heavy volume, despite no new company news, after a major holder, HRT Financial LP, disclosed selling nearly 58,000 shares last week; with a tiny $1.23 million market cap and under 900,000 shares outstanding, the stock’s price is highly sensitive to trading swings ahead of the regular session open.
Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Previous Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Tesco share price nudges toward 52-week high after UK retail sales jump — what to watch next
Next Story

Tesco share price nudges toward 52-week high after UK retail sales jump — what to watch next

Go toTop